Docetaxel
Product Images NDC 72485-214

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Docetaxel (NDC 72485-214). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (767b6901 F1ec 4d39 Bc9f D808f2ec95a3 01)

Chemical structure diagram of the active ingredient Docetaxel, showing its molecular framework with labeled atoms and bonds including rings, hydroxyl groups, and other functional groups.*

FDA Label Image

Image (767b6901 F1ec 4d39 Bc9f D808f2ec95a3 02)

A line graph depicting disease-free survival (DFS) probability over time in months. Two survival curves labeled TAC and FAC show DFS probabilities declining from near 100% to about 70-75% over a 66-month period.*

FDA Label Image

Image (767b6901 F1ec 4d39 Bc9f D808f2ec95a3 03)

A survival probability chart showing two survival curves labeled TAC and FAC. The x-axis represents survival time in months, ranging from 0 to 66, and the y-axis indicates survival probability percentage, ranging from 0% to 100%. The chart compares the survival probabilities over time for the two groups.*

FDA Label Image

Image (767b6901 F1ec 4d39 Bc9f D808f2ec95a3 04)

A survival curve chart showing cumulative probability versus survival time in months. The chart compares overall survival between two groups labeled T75 and BSC, with a log-rank p-value of 0.010 indicated on the graph. The cumulative probability scale ranges from 0 to 1.0, and survival time extends up to 21 months.*

FDA Label Image

Image (767b6901 F1ec 4d39 Bc9f D808f2ec95a3 05)

A Kaplan-Meier survival curve chart showing cumulative survival probability over time in months. Two lines represent different groups (T75 and V/1) with a legend. The chart includes an overall survival log-rank p-value of 0.13, comparing the survival distributions between groups.*

FDA Label Image

Image (767b6901 F1ec 4d39 Bc9f D808f2ec95a3 06)

A survival probability graph showing survival time in months on the x-axis and survival probability on the y-axis. It compares two groups labeled T75 q3w and M q3w with lines depicting survival trends over approximately 30 months.*

FDA Label Image

Image (767b6901 F1ec 4d39 Bc9f D808f2ec95a3 07)

A Kaplan-Meier survival curve graph depicting probability (%) over time (months) for two groups labeled TFC and CF. The graph shows survival probability decreasing over 24 months, with the TFC group consistently demonstrating higher survival probability than the CF group.*

FDA Label Image

Image (767b6901 F1ec 4d39 Bc9f D808f2ec95a3 08)

A survival probability curve showing survival time in months on the x-axis and survival probability percentage on the y-axis. Two lines are plotted representing groups labeled TFC and CF, depicting their respective survival probabilities over time.*

FDA Label Image

Image (767b6901 F1ec 4d39 Bc9f D808f2ec95a3 09)

A line graph showing Progression Free Survival (PFS) Probability (%) plotted against Progression Free Survival Time (months) for two groups labeled TFC and PF. The graph compares PFS probability over time for the two treatment groups.*

FDA Label Image

Image (767b6901 F1ec 4d39 Bc9f D808f2ec95a3 10)

A survival probability plot showing two survival curves labeled TPF and PF, depicting survival probability as a function of survival time in months. The vertical axis represents survival probability (%) and the horizontal axis shows survival time up to 72 months. The TPF curve indicates generally higher survival probabilities compared to PF over time.*

FDA Label Image

Image (767b6901 F1ec 4d39 Bc9f D808f2ec95a3 11)

A survival probability curve showing two groups, TPF and PF, over a survival time of up to 72 months. The y-axis represents survival probability (%) from 0 to 100%, and the x-axis shows survival time in months. A table below the x-axis lists the number of patients at risk for each group at various time points.*

FDA Label Image

Doce20 (Docelbl1)

Packaging labels for Docetaxel Injection, USP 20 mg/1 mL by Armas Pharmaceuticals Inc. The inner vial and outer carton labels show that it is a ready-to-add-to-infusion-solution intravenous infusion, single-use vial containing 1 mL. Labels include warnings, storage instructions, manufacturer information (Shilpa Medicare Limited, India), and barcodes with NDC 72485-214-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.